We identified c-Myc as the upstream regulator increasing the dependency of platinum resistant ovarian cancer cell lines on glutamine metabolism via the TCA cycle and in the regulation of oxidative phosphorylation. This evidence concerns the gene MYC and ovarian carcinoma.